Ronald Perrone
Co-Director, Polycystic Kidney Disease Outcomes Consortium · Tufts Medical Center
Credentials: · · · ·
History
PresentPolycystic Kidney Disease Outcomes Consortium · Tufts Medical Center
- 1975–1978
Internal Medicine
- 1971–1975
HAHNEMANN UNIV SCH OF MED, PHILADELPHIA
Research
Annals of Internal Medicine · 2003 · 3,531 citations
Tolvaptan in patients with autosomal dominant polycystic kidney disease
New England Journal of Medicine · 2012 · 1,273 citations
Serum creatinine as an index of renal function: new insights into old concepts
Review · Clinical Chemistry · 1992 · First of 3 authors · 1,161 citations
68 papers
63 papers
- TS
29 papers
- KB
28 papers
27 papers
- FC
21 papers
- WB
21 papers
20 papers
Grants
- 2002–2016
Clinical Centers for the HALT-Polycystic Kidney Disease Trials (U01)
National Institute of Diabetes and Digestive and Kidney Diseases · U01
Contact PI · $9.3M · Tufts Medical Center
- 1986–1989
Aldosterone Induced Colonic h+ Secretion & Vesicles
National Institute of Diabetes and Digestive and Kidney Diseases · R01
Contact PI · $366.4K · Tufts Medical Center
Clinical trials
- 2014–2016
Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease
Principal investigator · Completed · Phase 2, Phase 3
Tufts Medical Center
- 2006–2014
HALT Progression of Polycystic Kidney Disease Study A
Principal investigator · Completed · Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2006–2014
HALT Progression of Polycystic Kidney Disease Study B
Principal investigator · Completed · Phase 3
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- 2026–2030
Bempedoic Acid Therapy for Polycystic Kidney Disease
Sub-investigator · Not yet recruiting · Phase 2
Kenneth Hallows